- Nigerian woman with long-term effects of the parasitic river blindness
- Mike Urban
What if you could treat a poor person in Africa to cure or prevent seven horrible afflictions – river blindness, hookworm, elephantiasis, trachoma, snail fever and two other parasitic worm diseases – for only 50 cents?
Better yet, what if the drug industry could be compelled to give more than a billion of the planet’s poorest people worldwide life-saving and curative drugs for free?
Well, you can and they were.
One of the world’s biggest efforts aimed at fighting the most neglected diseases of poverty has been underway for a few years now. Chances are, you know very little about it – which may be thanks to this massive project getting launched in 2012 with an incredibly boring name, the London Declaration on Neglected Tropical Diseases.
Uff da. The global health community desperately needs help with branding.
“It’s actually incredibly exciting,” said Julie Jacobson, a physician and program officer at the Bill & Melinda Gates Foundation. I ran into Jacobson, whom I’ve known for many years and who always seems both happy and excited, when we were commuting in opposite directions via bicycle in Seattle’s Ballard neighborhood a while ago. We didn’t actually collide, but I did make her stop to see what she was up to. Continue reading
This scientific finding got a little bit of media attention, but deserves more:
A cheap drug, called Ivermectin (or brand name Mectizan), that Merck originally made for dogs may become a useful new weapon against one of the world’s biggest killers, malaria.
It was discovered many years ago that this drug also works against other parasitic worms that cause river blindness (onchocerciasis) and elephantiasis (filariasis). Merck, apparently unaware that it is supposed to be an evil drug company, has for more than 15 years been donating this drug to poor countries in Africa to fight these debilitating diseases.
Malaria is also caused by a parasite. In a study funded by a Gates Foundation’s Grand Challenges Explorations grant, researchers at Colorado State University explored if the drug might also work against the malaria bug.
The study is published in this week’s American Journal of Tropical Medicine and Hygiene (which you can’t read because the scientific publishing community thinks they can get you pay to read it … and which may account for the relatively low number of news articles on this amazing discovery).
Here are a few other reports of note on this:
Karen Grepin’s Global Health Blog Maybe Now People Will Care About Onchocerciasis
Bill Brieger’s Malaria Free Future blog Novel idea, but can it be scaled?